Search for the latest oncology news by tumour type
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan…
An overwhelming majority of adults (93%) recognise a lump as a symptom of breast cancer,…
A new editorial explores the wide array of reasons why women who migrate to a…
Professor Tracey O’Brien, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, said…
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide, with a 5-year survival…
Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved…
A technique developed by University of Texas at Dallas and UT Southwestern Medical Center (USA)…
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white…
Women living and working in places with higher levels of fine particle air pollution are…